PaHa09g00790

Functional evidence

eggNOG

Preferred name: LOC104607872 | Seed ortholog: 337451.A0A443PUT1 | COG: S | eggNOG OG: Ank_2@131567|BN-7, Ank_2@1437183|PnG-26!, Ank_2@2759|hb-12, Ank_2@3398|BRd-16, Ank_4@131567|Og-18, PGG@131567|A-1*, PGG@1437183|EY-10!, PGG@33090|Z-5

Gene Ontology

GO:0000082 G1/S transition of mitotic cell cycle; GO:0000122 negative regulation of transcription by RNA polymerase II; GO:0000791 euchromatin; GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific; GO:0001650 fibrillar center; GO:0001817 regulation of cytokine production; GO:0002039 p53 binding; GO:0003674 molecular_function; GO:0003677 DNA binding; GO:0003682 chromatin binding; GO:0003712 transcription coregulator activity; GO:0003713 transcription coactivator activity; GO:0003714 transcription corepressor activity; GO:0003779 actin binding; GO:0005515 protein binding; GO:0005575 cellular_component; GO:0005634 nucleus; GO:0005654 nucleoplasm; GO:0005667 transcription regulator complex; GO:0005737 cytoplasm; GO:0005829 cytosol; GO:0005886 plasma membrane; GO:0006355 regulation of DNA-templated transcription; GO:0006357 regulation of transcription by RNA polymerase II; GO:0007519 skeletal muscle tissue development; GO:0008150 biological_process; GO:0009751 response to salicylic acid; GO:0009791 post-embryonic development; GO:0010628 positive regulation of gene expression; GO:0010629 negative regulation of gene expression; GO:0010832 negative regulation of myotube differentiation; GO:0010976 positive regulation of neuron projection development; GO:0014866 skeletal myofibril assembly; GO:0016605 PML body; GO:0030016 myofibril; GO:0030017 sarcomere; GO:0030907 MBF transcription complex; GO:0031432 titin binding; GO:0031674 I band; GO:0032991 protein-containing complex; GO:0035914 skeletal muscle cell differentiation; GO:0035994 response to muscle stretch; GO:0042826 histone deacetylase binding; GO:0043025 neuronal cell body; GO:0043065 positive regulation of apoptotic process; GO:0043066 negative regulation of apoptotic process; GO:0043422 protein kinase B binding; GO:0043517 positive regulation of DNA damage response, signal transduction by p53 class mediator; GO:0043565 sequence-specific DNA binding; GO:0045087 innate immune response; GO:0045214 sarcomere organization; GO:0045445 myoblast differentiation; GO:0045662 negative regulation of myoblast differentiation; GO:0045892 negative regulation of DNA-templated transcription; GO:0045944 positive regulation of transcription by RNA polymerase II; GO:0048471 perinuclear region of cytoplasm; GO:0050714 positive regulation of protein secretion; GO:0051726 regulation of cell cycle; GO:0055008 cardiac muscle tissue morphogenesis; GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding; GO:0062040 fungal biofilm matrix; GO:0070412 R-SMAD binding; GO:0071222 cellular response to lipopolysaccharide; GO:0071260 cellular response to mechanical stimulus; GO:0071347 cellular response to interleukin-1; GO:0071356 cellular response to tumor necrosis factor; GO:0071363 cellular response to growth factor stimulus; GO:0071456 cellular response to hypoxia; GO:0071466 cellular response to xenobiotic stimulus; GO:0071560 cellular response to transforming growth factor beta stimulus; GO:0097730 non-motile cilium; GO:0141212 phospholipase C/protein kinase C signal transduction; GO:1902253 regulation of intrinsic apoptotic signaling pathway by p53 class mediator; GO:1990145 maintenance of translational fidelity; GO:2000279 negative regulation of DNA biosynthetic process; GO:2000288 positive regulation of myoblast proliferation; GO:2000291 regulation of myoblast proliferation

KEGG

KO: K21435 | Pathway: 04011, 04111, 04113, 04820 | BRITE: 00001, 03036